The Journal of the American Dental Association
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Am Dent Assoc, Vol 139, No 12, 1592-1601.
© 2008 American Dental Association

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fox, P. C.
Right arrow Articles by McLean, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fox, P. C.
Right arrow Articles by McLean, L.

COVER STORY

Oral involvement in primary Sjögren syndrome



Philip C. Fox, DDS, FDS, RCSEd, Simon J. Bowman, PhD, FRCP, Barbara Segal, MD, Frederick B. Vivino, MD, FACR, Nandita Murukutla, PhD, Karen Choueiri, MA, Sarika Ogale, PhD and Lachy McLean, PhD, FRCP

Background. In small studies, investigators have described oral features and their sequelae in primary Sjögren syndrome (PSS), but they have not provided a full picture of the aspects and implications of oral involvement. The authors describe what is, to their knowledge, the first large-scale evaluation to do so. In addition, they report data regarding utilization and cost of dental care among patients with PSS.

Methods. The authors surveyed patients with primary Sjögren syndrome as identified by their physicians (PhysR-PSS), patient-members of the Sjögren’s Syndrome Foundation (SSF-PSS) and control subjects who did not have PSS. They made comparisons between the three groups.

Results. Subjects were 277 patients with PhysR-PSS, 1,225 patients with SSF-PSS and 606 control subjects. More than 96 percent of those in the patient groups experienced oral problems. An oral complaint was the initial symptom in more than one-half of the patients. Xerostomia-associated signs and symptoms were common and severe, as evidenced by scores on an inventory of sicca symptoms. These patients’ rate of dental care utilization was high, and the care was costly.

Conclusions. Oral and dental disease in PSS is extensive and persistent and represents a significant burden of illness.

Clinical Implications. Oral symptoms and signs are common in patients with PSS. Early recognition of the significance of these findings by oral specialists could accelerate diagnosis and minimize oral morbidities.

Key Words: Oral symptoms; primary Sjögren syndrome; quality of life; dental spending

Abbreviations: AECG: American-European Consensus Group. • PhysR-PSS: Physician-referred patient–primary Sjögren syndrome. • PROFAD-SSI: Profile of Fatigue and Discomfort–Sicca Symptoms Inventory. • PSS: Primary Sjögren syndrome. • SF-36: Medical Outcomes Study 36-Item Short Form Health Survey. • SS: Sjögren syndrome. • SS-A (Ro): Sjögren syndrome antibody-A. • SS-B (La): Sjögren syndrome antibody-B. • SSF: Sjögren’s Syndrome Foundation. • SSF-PSS: Sjögren’s Syndrome Foundation–primary Sjögren syndrome.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright©1995-2008 American Dental Association (ADA).
Reproduction or republication strictly prohibited without prior written permission of ADA.